Recombinant Human IL-22RA2 (C-6His)

Description

EnkiLife provides the Recombinant Human IL-22RA2 (C-6His) protein,aslo know as Interleukin-22 Receptor Subunit Alpha-2,IL-22 Receptor Subunit Alpha-2,IL-22R-Alpha-2,IL-22RA2,Cytokine Receptor Class-II Member 10,Cytokine Receptor Family 2 Member 10,CRF2-10,Cytokine Receptor Family Type 2 Soluble 1,CRF2-S1,Interleukin-22-Binding Protein,IL-22BP,IL22BP,ZcytoR16,IL22RA2, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Interleukin-22 Receptor Subunit Alpha-2/Interleukin-22 Binding Protein is produced by our Mammalian expression system and the target gene encoding Thr22-Pro231 is expressed with a 6His tag at the C-terminus.Accession:Q969J5-2. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:25.7 KDa. Background:Interleukin-22 Receptor Subunit α-2 (IL22RA2) belongs to the type II cytokine receptor family. IL22RA2 is a secreted protein and contains three fibronectin type-III domains. IL22RA2 is widely expressed in many tissues. IL22RA2 functions as an IL22 antagonist and may be important in the regulation of inflammatory response. Three alternatively spliced transcript variants encoding distinct isoforms have been described.